PPHM Insider Trading Activity and SEC Form 4 Filings
PPHM insider trading summary
No open-market insider purchases or sales of Peregrine Pharmaceuticals Inc (PPHM) have been reported on SEC Form 4 in the past 12 months.
Latest PPHM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 27, 2017 | Mark R Bamforth | Director | Buy | $8K (1,800 @ $4.49) |
| Oct 27, 2017 | Mark R Bamforth | Director | Buy | $1K (300 @ $4.49) |
| Oct 27, 2017 | Mark R Bamforth | Director | Buy | $895 (200 @ $4.48) |
| Oct 27, 2017 | Mark R Bamforth | Director | Buy | $903 (201 @ $4.49) |
| Oct 27, 2017 | Mark R Bamforth | Director | Buy | $162K (35,966 @ $4.51) |
| Oct 27, 2017 | Mark R Bamforth | Director | Buy | $5K (1,200 @ $4.51) |
| Oct 27, 2017 | Mark R Bamforth | Director | Buy | $24K (5,340 @ $4.49) |
| Oct 27, 2017 | Mark R Bamforth | Director | Buy | $22K (4,993 @ $4.49) |
| Mar 14, 2012 | Eric S Swartz | Director | Buy | $10K (16,000 @ $0.62) |
| Nov 8, 2010 | Eric S Swartz | Director | Buy | $13K (8,400 @ $1.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.